No abstract available.
Erythema Infectiosum*

Humans ; Erythema Infectiosum ; Lymphadenopathy

OBJECTIVETo study the relationship between human parvovirus B19 infection and childhood idiopathic thrombocytopenic purpura (ITP) by the principle of evidence based medicine.

METHODSPapers related to the relationship between human parvovirus B19 infection and childhood ITP published between 1994 and 2008 were retrieved electronically from the Chinese Journals Full-text Database and the Wanfang Data. These relevant papers on case-control trials were statistically studied by meta analysis.

RESULTSEight papers that met the inclusion criteria were included for this meta analysis. Five hundred and sixteen cases of childhood ITP and 246 healthy controls were enrolled. The meta analysis showed that the incidence of human parvovirus B19 infection in the ITP group was significantly higher than that in the control group (OR=13.71, 95% CI=7.07-26.59, Z=7.75, p<0.01).

CONCLUSIONSHuman parvovirus B19 infection is closely associated with childhood ITP.

Hereditary spherocytosis (HS) is a genetic disorder characterized by the production and destruction of spherocytes due to a deficiency of red cell membrane cytoskeletal proteins, resulting in the clinical presentation of chronic hemolytic anemia. This disease can be accompanied by an aplastic crisis due to parvovirus B19 infection. Parvovirus B19 infection causes diseases such as erythema infectiosum and arthritis, and can also trigger various autoimmune diseases, including autoimmune hemolytic anemia (AIHA). Here, we report a rare case of AIHA developing 3 months after an aplastic crisis due to parvovirus B19 infection in an 11-year-old boy with HS and provide the relevant literature review.
Anemia, Hemolytic ; Anemia, Hemolytic, Autoimmune ; Arthritis ; Autoimmune Diseases ; Cell Membrane ; Child ; Cytoskeletal Proteins ; Erythema Infectiosum ; Humans ; Parvovirus ; Spherocytes ; Spherocytosis, Hereditary

Hereditary spherocytosis (HS) is a genetic disorder characterized by the production and destruction of spherocytes due to a deficiency of red cell membrane cytoskeletal proteins, resulting in the clinical presentation of chronic hemolytic anemia. This disease can be accompanied by an aplastic crisis due to parvovirus B19 infection. Parvovirus B19 infection causes diseases such as erythema infectiosum and arthritis, and can also trigger various autoimmune diseases, including autoimmune hemolytic anemia (AIHA). Here, we report a rare case of AIHA developing 3 months after an aplastic crisis due to parvovirus B19 infection in an 11-year-old boy with HS and provide the relevant literature review.
Anemia, Hemolytic ; Anemia, Hemolytic, Autoimmune ; Arthritis ; Autoimmune Diseases ; Cell Membrane ; Child ; Cytoskeletal Proteins ; Erythema Infectiosum ; Humans ; Parvovirus ; Spherocytes ; Spherocytosis, Hereditary

Human parvovirus B19 (B19 virus) is one of the two parvoviruses that cause human diseases. As an important pathogen to humans, it causes infectious erythema in children, acute aplastic anemia, fetal edema and death. In this review, we focus on the recent advances in the molecular virology of B19V, such as viral genotypes, viral receptor, genomic features and viral replication, viral transcription and post-transcription regulation, viral nonstructural and structural protein features and functions, viral diagnosis and antiviral agents, to provide reference for further study of B19 pathogenesis mechanisms, treatment and diagnostic strategies.
Antiviral Agents ; DNA, Viral ; genetics ; Erythema Infectiosum ; diagnosis ; virology ; Genotype ; Humans ; Parvovirus B19, Human ; genetics ; Virology ; trends ; Virus Replication

The acquired immunodeficiency syndrome patients with compromised immunity are prone to hemophagocytic syndrome secondary to opportunistic infections.This paper reports a rare case of hemophagocytic syndrome secondary to human parvovirus B19 infection in an acquired immunodeficiency syndrome patient,and analyzes the clinical characteristics,aiming to improve the diagnosis and treatment of the disease and prevent missed diagnosis and misdiagnosis.
Humans ; Lymphohistiocytosis, Hemophagocytic/drug therapy* ; Erythema Infectiosum/complications* ; Acquired Immunodeficiency Syndrome/complications* ; Parvoviridae Infections/diagnosis* ; Parvovirus B19, Human

BACKGROUND: The pathogenic human parvovirus B19 is the etiologic agent of erythema infectiosum and causes other events including aplastic crisis,hydrops fetalis and fetal loss.Recently,it has been reported in many articles that human parvovirus B19 infection is associated with rheumatoid arthritis (RA).In contrast to these reports from the United Kingdom,Germany,Japan and China,different results were reported that there is no association between human parvovirus B19 and the pathogenesis of RA in Northern Ireland,Finland and France.This study aimed to investigate the association between human parvovirus B19 and RA in Korea. METHODS: Sera from 104 patients with RA,40 with osteoarthritis (OA)and 32 with systemic lupus erythematosus (SLE)were tested for IgG and IgM of human parvovirus B19 by ELISA (Biotrin),respectively. RESULTS: There were no statistical differences among RA,OA and SLE patients in both anti-human parvovirus B19 IgG and IgM (p>0.05).Human parvovirus B19 IgM was positive in only four RA patients and negative in all SLE and OA patients. CONCLUSION: Human parvovirus B19 infection showed no association with RA in Korea,which is different from reports from other countries,especially Japan and China which are our neighbors.We thought that this result was due to the ethnic or national differences of baseline titer of anti-human parvovirus B19.Therefore anti-human parvovirus B19 test for RA patients is not necessary in Korea.In conclusion,we suggest that the indication and interpretation of anti-human parvovirus B19 testing in RA patients should be applied differently for each nation.
Arthritis, Rheumatoid* ; China ; Enzyme-Linked Immunosorbent Assay ; Erythema Infectiosum ; Humans* ; Immunoglobulin G ; Immunoglobulin M ; Japan ; Korea* ; Lupus Erythematosus, Systemic ; Osteoarthritis ; Parvovirus ; Parvovirus B19, Human*

BACKGROUND: The pathogenic human parvovirus B19 replicates only in erythroid progenitor cells. The blood-group P antigen has been reported to be the cellular receptor of this virus. Human parvovirus B19 is known to be the etiologic agent of erythema infectiosum and causes a chronic anemia resulting from a persistent infection in immunocompromised patients. Recently, it has been re-ported to play a role in rheumatoid arthritis activity (RA). This study was aimed to determine whether human parvovirus B19 has a role to play in chronic anemia of RA which is the case in immunocompromised patients. We also investigated the association between the activity of the disease in RA and human parvovirus B19 infections. METHODS: Of 107 patients that had RA, 49 patients had anemia and 58 patients did not. We used ESR and CRP results to estimate the degree of disease activity. Thirty-eight patients having RA had a normal ESR and 69 patients had a high ESR. Sixty patients had normal CRP and 47 patients had high CRP. Sera of patients were tested for the presence of anti-human parvovirus B19 (IgG and IgM) using ELISA (Biotrin, Co. Dublin, Ireland). RESULTS: Of 107 patients who had RA, 79.4% (85/107) and 3.7% (4/107) were positive for IgG and IgM, respectively. There were no statistical differences between RA patients with anemia and those without anemia in the anti-human parvovirus B19 test (P>0.05). There were also no statistical differences between patients that had a normal or high ESR/CRP ratio (P>0.05). CONCLUSIONS: Human parvovirus B19 did not play a role in the formation of the chronic anemia of RA which is different from the cases of immunocompromised patients. Furthermore, we found no association between disease activity in RA and human parvovirus B19 infections.
Anemia* ; Arthritis, Rheumatoid* ; Enzyme-Linked Immunosorbent Assay ; Erythema Infectiosum ; Erythroid Precursor Cells ; Humans* ; Immunocompromised Host ; Immunoglobulin G ; Immunoglobulin M ; Parvovirus ; Parvovirus B19, Human*

Human parvovirus(HPV) B19 infection causes erythema infectiosum in children, sometimes red cell aplastic crisis with hemolytic anemia and chronic bone marrow failure in immunocompromised hosts. HPV B19 is directly cytotoxic for erythroid progenitor cells and inhibits erythropoiesis. Infrequently, HPV B19 inhibits hematopoiesis of three cell lineages and causes transient pancytopenia in patients with hemolytic disorders. We report three patients with hereditary spherocytosis who developed transient aplastic crisis. A HPV B19 infection was confirmed by IgM anti-B19 parvovirus titers and characteristic findings of bone marrow examination as the causative agent associated with severe pancytopenia. Three patients recovered spontaneously after a short period of supportive care with red cell transfusions and intravenous immunoglobulin.
Anemia, Hemolytic ; Bone Marrow ; Bone Marrow Examination ; Cell Lineage ; Child ; Erythema Infectiosum ; Erythroid Precursor Cells ; Erythropoiesis ; Hematopoiesis ; Humans ; Immunocompromised Host ; Immunoglobulin M ; Immunoglobulins ; Pancytopenia ; Parvovirus*